Disease/Infection News

RSS

Risk assessment of the threat of SARS-CoV-2 on banknotes

A new study evaluates the risk of SARS-CoV-2 exposure by fomite transmission during cash transactions.

7 Dec 2021

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

Scientists develop an improved biosensor with Cas12a-based CRISPR on-site rapid detection system and discuss its ability to detect SARS-CoV-2 VOCs.

7 Dec 2021

SARS-CoV-2 re-infection from new variant after natural infection

Researchers survey incidences of SARS-CoV-2 infection in both care home staff and residents early in the pandemic.

7 Dec 2021

Delays in hospitals' cardiac care services mount during COVID-19 pandemic

Researchers analyzed 94 papers related to the delivery of healthcare services during the COVID-19 pandemic.

7 Dec 2021

SARS-CoV-2 Delta variant changes receptor binding domain conformation to escape host antibodies

Researchers investigate the conformational dynamics of the SARS-CoV-2 RBD using the atomistic molecular dynamics simulation method.

7 Dec 2021

Delta SARS-CoV-2 variant drove increase in infection numbers in the U.K.

Researchers determine how different the SARS-CoV-2 Delta variant was from the previously dominant Alpha variant.

7 Dec 2021

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination.

7 Dec 2021

Convalescent plasma not recommended for patients with covid-19, WHO experts say

Convalescent plasma (a transfusion of blood plasma from someone who has recovered from covid-19) is not recommended for patients with covid-19, says a WHO Guideline Development Group of international experts in The BMJ today.

7 Dec 2021

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Led by computational researchers from WEHI, in collaboration with The University of Queensland, Queensland University of Technology and Hospital Marcelino Champagnat in Brazil, the study used advanced spatial transcriptomic techniques to screen for genes associated with excessive inflammation in the lungs, a key indicator of severe COVID-19.

7 Dec 2021

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

Researchers examined autopsy tissue samples of hearts from patients who died early in the COVID-19 pandemic.

7 Dec 2021

Community mask usage reduces symptomatic COVID seroprevalence in Bangladesh

A new Science preprint explores the effectiveness of universal masking in reducing the incidence of symptomatic disease.

7 Dec 2021

Early warning signals could aid in the monitoring of disease outbreaks, research suggests

New research suggests early warning signals (EWSs) could help in the monitoring of disease outbreaks, such as COVID-19.

7 Dec 2021

CDC awards $22 million to fight antimicrobial resistance through the launch of two new networks

The Centers for Disease Control and Prevention (CDC) announced today that it has awarded $22 million to nearly 30 organizations around the world to combat antimicrobial resistance (AR) and other healthcare threats through the establishment of two new networks - the Global Action in Healthcare Network (GAIHN) and the Global AR Laboratory and Response Network (Global AR Lab & Response Network).

7 Dec 2021

People who exercise regularly have lower risk of developing and dying from pneumonia

People who exercise regularly can reduce their risk of developing and dying from pneumonia, new research has found.

7 Dec 2021

Poolbeg and University College Dublin sign an Option Agreement to license melioidosis vaccine candidate

Poolbeg Pharma, 'Poolbeg' or the 'Company', a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has signed an Option Agreement to licence MelioVac, a vaccine for melioidosis, with University College Dublin and its inventor, Associate Professor Siobhán McClean, through NovaUCD, the university's knowledge transfer office.

7 Dec 2021

Disease/Infection News

Risk assessment of the threat of SARS-CoV-2 on banknotes

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

SARS-CoV-2 re-infection from new variant after natural infection

Delays in hospitals' cardiac care services mount during COVID-19 pandemic

SARS-CoV-2 Delta variant changes receptor binding domain conformation to escape host antibodies

Delta SARS-CoV-2 variant drove increase in infection numbers in the U.K.

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Convalescent plasma not recommended for patients with covid-19, WHO experts say

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

Community mask usage reduces symptomatic COVID seroprevalence in Bangladesh

Early warning signals could aid in the monitoring of disease outbreaks, research suggests

CDC awards $22 million to fight antimicrobial resistance through the launch of two new networks

People who exercise regularly have lower risk of developing and dying from pneumonia

Poolbeg and University College Dublin sign an Option Agreement to license melioidosis vaccine candidate

Study: European governments struggled to maintain public trust during the pandemic

SARS-CoV-2 surveillance in urban wildlife from Ontario and Québec

Multiplex proteomic panel assay for assessment of disease severity and outcome prediction in COVID-19

Impact of infection control measures and vaccines in protecting healthcare workers from COVID-19

Stand Up To Cancer - An Interview with Chris Draft

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News